Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NTSR2 antagonists(neurotensin receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H26F3N3O6S |
InChIKeySOOLLEBJNGCDOZ-FQEVSTJZSA-N |
CAS Registry1623002-61-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | US | 11 Sep 2014 |